Drug sales up 12.6% annually since 1988
S Martin - CMAJ, 2003 - Can Med Assoc
The Patented Medicine Prices Review Board (PMPRB) says sales of pharmaceuticals for
human use in Canada topped $13.1 billion in 2002, up $1.6 billion (13.9%) from 2001 …
human use in Canada topped $13.1 billion in 2002, up $1.6 billion (13.9%) from 2001 …
Drug prices stable but total spending rises by 15%
L Buske - 2002 - Can Med Assoc
The annual report of the Patented Medicine Prices Review Board indicates that
manufacturers' total sales of pharmaceuticals reached $11.5 billion in Canada in 2001, a …
manufacturers' total sales of pharmaceuticals reached $11.5 billion in Canada in 2001, a …
Regulating the price of patented drugs
Canadian Medical Association - CMAJ, 1997 - Can Med Assoc
The Patented Medicine Prices Review Board was es-tablished in 1987 to protect consumers
against excessive prices by regulating the maximum price of each patented drug on the …
against excessive prices by regulating the maximum price of each patented drug on the …
Spending on drugs approaching $15 billion a year: CIHI
B Sibbald - 2001 - Can Med Assoc
Canadians spent $14.7 billion on drugs in 2000, an increase of about 10% over the previous
year, the Canadian Institute for Health Information (CIHI) reports. And while the makers of …
year, the Canadian Institute for Health Information (CIHI) reports. And while the makers of …
Prescription Drug Prices in Canada and the United States, Part 2: Why the Difference?
JR Graham - 2000 - policycommons.net
This study compares the prices of prescription drugs in Canada and the United States. The
measure used is the replacement cost, at Canadian prices, of drugs consumed by the …
measure used is the replacement cost, at Canadian prices, of drugs consumed by the …
Prescription Drug Prices in Canada and the United States, Part 1: A Comparative Survey
JR Graham - 2000 - policycommons.net
This study compares the prices of prescription drugs in Canada and the United States. The
measure used is the replacement cost, at Canadian prices, of drugs consumed by the …
measure used is the replacement cost, at Canadian prices, of drugs consumed by the …
Generic Drugopoly: Why Non-patented Prescription Drugs Cost More in Canada than in the United States and Europe
BJ Skinner - 2004 - policycommons.net
Studies comparing international prices of prescription pharmaceuticals have found that
Canadian prices are close to the international median price for patented drugs but higher for …
Canadian prices are close to the international median price for patented drugs but higher for …
[HTML][HTML] Marketing before patenting: implications for price controls in Canada
J Lexchin - Open Medicine, 2010 - ncbi.nlm.nih.gov
Abstract The Patented Medicine Prices Review Board (PMPRB) regulates the introductory
price of new patented medications in Canada. Some drugs are marketed before they are …
price of new patented medications in Canada. Some drugs are marketed before they are …
Drugs taking bigger bite of health care pie
L Buske - 2001 - Can Med Assoc
Pharmaceuticals account for the fastest growing component of health care costs in Canada,
with average growth rates that are 3 times the annual rate of inflation. The Patented Medical …
with average growth rates that are 3 times the annual rate of inflation. The Patented Medical …
Reforms to the patented medicine prices review board and the introduction of new drugs in Canada: An observational study
J Lexchin - Health Policy, 2022 - Elsevier
Abstract Background Innovative Medicines Canada has said that companies are delaying
the introduction of new drugs into Canada in anticipation of changes in how the Patented …
the introduction of new drugs into Canada in anticipation of changes in how the Patented …